Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $116.81 | 7 | 78.6% |
| Education | $31.71 | 2 | 21.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Senseonics, Incorporated | $34.00 | 2 | $0 (2018) |
| Strongbridge US INC. | $22.22 | 1 | $0 (2018) |
| MannKind Corporation | $20.00 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.48 | 1 | $0 (2018) |
| Roche Diabetes Care, Inc. | $15.53 | 1 | $0 (2018) |
| Novo Nordisk Inc | $15.41 | 1 | $0 (2024) |
| Abbott Laboratories | $13.17 | 1 | $0 (2018) |
| Lilly USA, LLC | $11.71 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.41 | 1 | Novo Nordisk Inc ($15.41) |
| 2023 | $20.00 | 1 | MannKind Corporation ($20.00) |
| 2022 | $11.71 | 1 | Lilly USA, LLC ($11.71) |
| 2018 | $101.40 | 6 | Senseonics, Incorporated ($34.00) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
| 04/21/2023 | MannKind Corporation | AFREZZA (Drug) | Education | In-kind items and services | $20.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 06/10/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 10/18/2018 | Senseonics, Incorporated | Eversense (Device) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Endocrinology | ||||||
| 08/29/2018 | Senseonics, Incorporated | Eversense (Device) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Endocrinology | ||||||
| 08/09/2018 | Strongbridge US INC. | MACRILEN (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Endocrinology | ||||||
| 05/31/2018 | Roche Diabetes Care, Inc. | DC ACCU-CHEK FASTCLIX Lancet and Device Kit (Device) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Diabetes Care | ||||||
| 01/23/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, SYNJARDY XR | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: DIABETES | ||||||
| 01/05/2018 | Abbott Laboratories | FreeStyle Libre Pro (Device) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 276 | 519 | $180,967 | $40,250 |
| 2022 | 5 | 308 | 572 | $101,940 | $45,647 |
| 2021 | 5 | 322 | 582 | $87,760 | $46,840 |
| 2020 | 5 | 290 | 498 | $82,772 | $34,198 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 199 | 354 | $150,450 | $33,716 | 22.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 37 | 124 | $12,772 | $3,055 | 23.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $11,052 | $2,303 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 23 | $6,693 | $1,176 | 17.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 205 | 362 | $74,953 | $35,660 | 47.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 34 | 34 | $9,034 | $4,713 | 52.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 27 | 126 | $12,978 | $3,231 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 27 | $4,147 | $1,515 | 36.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 15 | 23 | $828.00 | $527.62 | 63.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 186 | 342 | $62,688 | $36,637 | 58.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 23 | 23 | $5,336 | $3,023 | 56.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 51 | $6,591 | $2,926 | 44.4% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 33 | 107 | $11,021 | $2,814 | 25.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 33 | 59 | $2,124 | $1,439 | 67.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 160 | 326 | $60,185 | $24,691 | 41.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 80 | 86 | $11,074 | $4,295 | 38.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 23 | 23 | $5,336 | $3,097 | 58.0% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 14 | 50 | $5,150 | $1,362 | 26.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 13 | $1,027 | $753.30 | 73.3% |
About Dr. Donald Rose, MD
Dr. Donald Rose, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851351951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donald Rose, MD has received a total of $148.52 in payments from pharmaceutical and medical device companies, with $15.41 received in 2024. These payments were reported across 9 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($116.81).
As a Medicare-enrolled provider, Rose has provided services to 1,196 Medicare beneficiaries, totaling 2,171 services with total Medicare billing of $166,935. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Winston Salem, NC
- Active Since 03/24/2006
- Last Updated 10/28/2020
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1851351951
Products in Payments
- Eversense (Device) $34.00
- MACRILEN (Drug) $22.22
- AFREZZA (Drug) $20.00
- JARDIANCE (Drug) $16.48
- DC ACCU-CHEK FASTCLIX Lancet and Device Kit (Device) $15.53
- Ozempic (Drug) $15.41
- FreeStyle Libre Pro (Device) $13.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Winston Salem
John Phipps, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $35,369
Dr. Amanda Cunningham, M.d,, M.D,
Endocrinology, Diabetes & Metabolism — Payments: $17,356
Dr. Michael Altheimer, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $5,520
Dr. Kellie Faulk, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $2,081
Dr. Jaime Trujillo, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,996
Dr. Mark Guido, M.d,, M.D,
Endocrinology, Diabetes & Metabolism — Payments: $1,175